Aytu BioPharma Inc. Insider Trading

AYTU

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jun 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Jun 2025

Jun 9, 2025

Get an email when AYTU's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 9, 2025	Jarrett Disbrow Chief Business Officer	Bought	16,666	$1.50	25K	130%	Form 4
Jun 9, 2025	Joshua R. Disbrow Chief Executive Officer	Bought	66,666	$1.50	100K	77%	Form 4
Feb 28, 2025	Joshua R. Disbrow Chief Executive Officer	Bought	15,000	$1.30	20K	21%	Form 4

Jun 9, 2025
Jarrett Disbrow
Chief Business Officer · bought 16,666 at $1.50
25K
130% of stake
Jun 9, 2025
Joshua R. Disbrow
Chief Executive Officer · bought 66,666 at $1.50
100K
77% of stake
Feb 28, 2025
Joshua R. Disbrow
Chief Executive Officer · bought 15,000 at $1.30
20K
21% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AYTU, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with AYTU

CompareIntrinsic value

NKTRNektar Therapeutics Inc.

$38.48+1.91%25

PRTAProthena Corporation plc

$8.39+2.19%25

AQSTAquestive Therapeutics Inc.

$3.80-2.06%10

BCYCBicycle Therapeutics PLC

$3.72+1.36%40

TNGXTango Therapeutics Inc.

$23.18+0.04%40

QTTBQ32 Bio Inc.

$8.97+2.40%60

SIGASiga Technologies Inc.

$3.15+1.29%20

GOSSGossamer Bio Inc.

$9.40+1.29%10

Spot a number that looks wrong? Check it in AYTU's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AYTU

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.